First human doses given in new drug safety trial
NCT ID NCT07343323
Summary
This is the first study to test a new drug called KINE-101 in humans. It enrolled 40 healthy volunteers to check if the drug is safe and to see how the body absorbs and processes it. Participants received either the drug or a placebo (inactive substance) as a single injection or infusion, and researchers closely monitored their health for side effects over several weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Parexel International
Baltimore, Maryland, 21225, United States
Conditions
Explore the condition pages connected to this study.